Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) Arthroplasty
1 other identifier
interventional
53
1 country
1
Brief Summary
Thumb carpometacarpal (CMC) arthritis affect 1 in 4 females and 1 in 12 males. Patients who fail to respond to conservative treatment may benefit from surgery; however, controversy exists over the most effective surgical technique. A popular technique, ligament reconstruction with tendon interposition (LRTI) involves a trapeziectomy, followed by reconstruction of the palmar oblique ligament using a harvested flexor tendon from the wrist. We believe that use of a suture fixation system to reconstruct the palmar oblique ligament, instead of harvesting a wrist tendon, may provide a superior repair. The objective of this study is to compare functional outcome measurements among patients who receive CMC arthroplasty using a suture fixation system (investigational group) to those who receive LRTI surgery (control group). We hypothesize that patients in the investigational group will demonstrate superior functionality, compared to patients in the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2010
CompletedStudy Start
First participant enrolled
April 12, 2010
CompletedFirst Posted
Study publicly available on registry
May 12, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 21, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2012
CompletedAugust 15, 2018
August 1, 2018
2.1 years
April 9, 2010
August 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Overall functionality
Functionality will be assessed using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, which assesses functionality of the upper extremity, and Short Form 36 (SF-36) health outcomes assessment, which quantifies global functionality (not specific to the upper extremity).
Baseline
Overall Functionality
6 wks
Overall Functionality
3 mos
Overall Functionality
6 mos
Overall Functionality
12 months
Overall Functionality
24 months
Secondary Outcomes (5)
Analog pain scale
Baseline, 2 wks, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos
Strength measures
Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos
Range of motion
Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos
Operative time
Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos
Scaphometacarpal distance
Baseline, 6 wks, 3 mos, 6 mos, 12 mos, 24 mos
Study Arms (3)
LRTI
ACTIVE COMPARATORThese patients will undergo ligament reconstruction with tendon interposition (LRTI) surgery. They will serve as a control group, against which to compare the investigational surgical technique.
Suture fixation system
EXPERIMENTALCMC arthroplasty which reconstructs palmar oblique ligament using a suture fixation system.
Suture fixation system + 2 week immobilization
EXPERIMENTALCMC arthroplasty which reconstructs palmar oblique ligament using a suture fixation system, and with a decreased immobilization time from 6 to 2 weeks post-surgery.
Interventions
CMC arthroplasty consisting of reconstruction of the palmar oblique ligament using a suture fixation system
commonly performed CMC arthroplasty technique, consisting of a trapeziectomy, followed by palmar oblique ligament reconstruction using a harvested flexor tendon from the wrist.
Eligibility Criteria
You may qualify if:
- Male or female patients aged \>18.
- Eaton Stage III or IV CMC arthritis
- Failure to respond to conservative treatment
You may not qualify if:
- Previous surgical interventions on that thumb
- Upper extremity neurological dysfunction
- Inability to effectively communicate with the research staff, due to hearing impairment, cognitive impairment, or a language barrier
- Unwilling or unable to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- J&M Shulerlead
Study Sites (1)
Athens Orthopedic Clinic
Athens, Georgia, 30606, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Shuler, MD
Athens Orthopedic Clinic, PA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Hand and Upper Extremity Specialist
Study Record Dates
First Submitted
April 9, 2010
First Posted
May 12, 2010
Study Start
April 12, 2010
Primary Completion
May 21, 2012
Study Completion
July 25, 2012
Last Updated
August 15, 2018
Record last verified: 2018-08